DNLI
Denali Therapeutics Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Denali Therapeutics (DNLI) Stock: Buy, Sell, or Hold?
$19.73
-0.12 (-0.60%)
âŧ
5d:
-5.87%
30d:
+7.23%
90d:
-20.51%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (42%)
Quality Score
49/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$18.33 â $20.13
Position: SLIGHTLY HIGH
Forward P/E & Valuation
-8.8x
Next 12M consensus est.
Wall Street Target
$36.19
+83.4% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$18.32 / $22.19
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: DNLI is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When DNLI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: DNLI is currently trading at $19.73, which is considered slightly high relative to its 30-day fair value range of $18.33 to $20.13.
Technical Outlook: Technically, DNLI is in a strong downtrend. Immediate support is located at $18.32, while resistance sits at $22.19.
Market Sentiment: DNLI scores 39/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $36.19 (+83.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, DNLI is in a strong downtrend. Immediate support is located at $18.32, while resistance sits at $22.19.
Market Sentiment: DNLI scores 39/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $36.19 (+83.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$18.33 -
$20.13
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
42.1%
Trading Range & Key Levels
30-Day Trading Range
$18.33 -
$20.13
Current vs Trading Range
SLIGHTLY HIGH
Support Level
$18.32
Resistance Level
$22.19
Current Trend
Strong Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BEARISH: Weak technical setup (39/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 83.4% below Wall St target ($36.19)
- WARNING: Composite score 49/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-8.84
Wall Street Target
$36.19
(+83.4%)
Revenue Growth (YoY)
-100.0%
Share DNLI Analysis
Share this live DNLI analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (DNLI)
Bullish
3 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Nov 4, 2026
Daily AI digest
AI Retail Discussion Summary:
Denali Therapeutics reported strong Q3 earnings, with AVLAYAH sales exceeding expectations and a permanent J-code now in effect. Shares rose 9.8% in after-hours trading.
Key Retail Themes:
Earnings beat and revenue surpassing estimates
Success of AVLAYAH, the first FDA-approved medicine for Hunter syndrome
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 2:19 AM ET
Data refreshes hourly during market hours. Next update: 3:19 AM
Data refreshes hourly during market hours. Next update: 3:19 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DNLI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
PRAX
Praxis Precision MedicinâĻ |
STRONG BUY
21 analysts |
$650 | 38 SELL |
|
NAMS
NewAmsterdam Pharma CompâĻ |
STRONG BUY
16 analysts |
$50 | 44 HOLD |
|
IMUX
Immunic Inc |
STRONG BUY
13 analysts |
$43 | 51 HOLD |
|
ACAD
ACADIA Pharmaceuticals IâĻ |
STRONG BUY
20 analysts |
$31 | 43 HOLD |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
17 analysts |
$34 | 39 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive DNLI Research Pages
